CompletedNot Applicable

Evaluation of the Novel Silq ClearTract Catheter in Patients With Chronic Urinary Retention

United States115 participantsStarted 2023-07-26

Plain-language summary

To assess the ability of the Silq ClearTract™ 100% Silicone 2-Way Foley Catheter to reduce catheter associated complications in subjects that require a long-term indwelling Foley catheter when compared to other commercially available Foley catheters.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * At least 18 years old * Requirement of a 14 Fr, 16Fr, or 18Fr indwelling urethral or suprapubic urinary catheter (for at least 6 months) for bladder drainage. * Able and willing to comply with study procedures * Able and willing to give informed consent. Exclusion Criteria: * History of reconstructive bladder surgery such as bladder augmentation or continent catheterizable stoma. * Cognitive deficit limiting the ability to respond to clinical questionnaires. * Allergy or sensitivity to any catheter material used in this study.

What they're measuring

Number of Catheter Related Complications

Timeframe: 6 months

Trial details

NCT IDNCT05931887

SponsorSilq Technologies Corporation

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2025-12-31

View on ClinicalTrials.gov More Catheter Infection trials